Wall Street equity research analysts tracking Molina Healthcare maintain average 12-month consensus price targets hovering around 192 to 195 US dollars per share. Individual institutional forecasts span across a wide range depending on quarterly medical loss ratios, regulatory updates, and enrollment trends, with some bullish analysts projecting higher targets and others maintaining conservative or cautious evaluations based on near-term healthcare sector cost pressures.